the shareholding in subsidiary companies To: President The Stock Exchange of Thailand Attachment: Structure of the shareholding in subsidiary companies Filter Vision Public Company Limited (“the Company
1/7 เลขท่ี 1 อาคาร ทีพี แอนด์ ที ชัน้ 14 ซอยวิภาวดีรังสติ 19 14th Floor, TP&T Tower 1 Soi Vibhavadee-Rangsit 19 Tel : (662) 936-1661-2 แขวงจตจุกัร เขตจตจุกัร กรุงเทพฯ 10900 Chatuchak, Chatuchak, Bangkok 10900, Thailand Fax : (662) 936-1669 ทะเบียนเลขท่ี 0107554000097 Registration No. 0107554000097 HYDROTEK PUBLIC COMPANY LIMITED บริษทั ไฮโดรเท็ค จ ำกดั (มหำชน) (Translation) No. 078/0960 21 September 2017 Subject: Notification of the Board of Directors No.8/2017 and the date of the Extraordinary...
Franchise Agreement; and the Agreement to Acquire and Dispose Assets of “Wuttisak Clinic” 25 Branches from Total 119 Branches dated February 9, 2018 Since Filter Vision Public Company Limited (“the Company
. SET-2017-002: Signing on the Franchise Agreement; and the Agreement to Acquire and Dispose Assets of “Wuttisak Clinic” 25 Branches from Total 119 Branches dated February 9, 2018 Since Filter Vision
regarding proper disclosure of information, which should reflect both past performance and a clear vision for future operations, with perspectives from investors who have direct experience in selecting
for ASEAN Sustainable Capital Markets (Roadmap) was endorsed by the ASEAN Finance Ministers’ and Central Bank Governors’ Meeting (AFMGM) in April 2019. The Roadmap promotes a common vision and
The 33rd ASEAN Capital Markets Forum (ACMF) Chairs’ Meeting virtually held today in Hanoi endorsed the key priorities for its Action Plan 2021 – 2025 to realise the ACMF Vision 2025 of being an inter
rights respect as well as the IOD’s vision to help strengthen efficiency of corporate board performance. Having female representation in the corporate boards will bring about diversity at board level
SEC Secretary-General, will share his insights on Thailand?s strength and advantage and his vision on ?Thailand: Regional Capital Market Gateway,? followed by Dr. Christopher Balding on ?Innovations in